Difficile measures

A missed diagnosis of Clostridium difficile infection can cost a hospital tens of thousands of dollars, Dr Glen Hansen, associate professor at the University of Minnesota, says. Now, with physicians still struggling to accurately spot and treat patients suffering from this difficult-to-detect illness, a pioneering detection method developed by immunodiagnostics company Singulex may offer healthcare professionals a better weapon in their battle against the disease.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.